RETATRUTIDE 20 MG KIT -(2-8 C) -4 MG / VIAL -5 VIALS

🧴 RETATRUTIDE – 20 MG KIT (4 MG / VIAL × 5 VIALS) – ZPHC PHARMA

🧪 Product Type

Peptide / Triple Receptor Agonist

Active Ingredient: Retatrutide

Dosage Form: Lyophilized Powder for Reconstitution

Total Content: 20 MG per kit (5 vials × 4 MG)

Manufacturer: ZPHC PHARMA

📄 Description

RETATRUTIDE 20 MG KIT from ZPHC PHARMA is a cutting-edge investigational peptide engineered to act as a triple agonist, targeting:

• GLP-1 (Glucagon-Like Peptide-1)
• GIP (Gastric Inhibitory Polypeptide)
• Glucagon Receptor

This unique receptor combination is under study for its potent effects on weight loss, metabolic regulation, and glucose control. Retatrutide represents the latest advancement in multi-targeted metabolic therapies, ideal for research into obesity, type 2 diabetes, and energy balance.

✅ Key Features

• 💉 Concentration: 4 MG per vial
• 🧪 Total Kit Strength: 20 MG (5 vials)
• 🔬 Form: Lyophilized powder for subcutaneous injection after reconstitution
• ❄️ Storage: Store refrigerated at 2°C – 8°C after mixing

⚙️ Mechanism of Action

Retatrutide binds to and activates GLP-1, GIP, and glucagon receptors, leading to:

• Reduced appetite and enhanced satiety
• Increased energy expenditure and fat oxidation
• Improved glycemic control via insulin sensitivity
• Potential weight reduction even in resistant obesity models

📈 Research Benefits

• 🔥 Promotes significant fat loss
• 💪 Preserves lean body mass during caloric deficit
• 🧠 May improve mood, cognitive function, and energy levels
• 📉 Reduces blood glucose and insulin resistance markers
• 🧬 Ideal for multi-faceted metabolic research protocols

💉 Suggested Research Use (Laboratory Use Only)

• Reconstitute each vial with bacteriostatic water
• Administer via subcutaneous injection
• Standard experimental doses vary based on subject type and study duration
• Typically dosed once weekly in extended-release trials

⚠️ Possible Side Effects

• Nausea or GI upset
• Decreased appetite
• Headache or fatigue
• Injection site redness
• Dose-dependent effects, often mild and temporary

🚫 Contraindications (For Research Exclusion Criteria)

• Active or past history of medullary thyroid carcinoma
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Allergy to peptide components
• Use in pregnant or lactating models not advised

🛒 Product Information

• Product Name: Retatrutide 20 MG KIT
• Contents: 5 Vials × 4 MG
• Manufacturer: ZPHC PHARMA
• Use: For Research Purposes Only – Not for Human Consumption
• Shipping: Delivered via trusted research suppliers
• Storage Conditions: Refrigerate post-reconstitution